Thursday, February 24, 2011

Aurobindo pharma

Aurobindo pharma
stock price Aurobindo Pharma Aurobindo Pharma in a filing with the Bombay Stock Exchange (BSE), the company said the provisional approval from the Food and Drug Administration (FDA) for different concentrations of 37.5 mg, 75 mg and 150 mg Capsules.Hydrochloride capsules, extended-release venlafaxine extended-release 37.5 mg, 75 mg and 150 mg, high at the beginning of @ 270 is going to do about 20% to 220 last week. This is the same margin as the other Sun, Cipla, Ramos, etc, all parties at points 20% plus or minus a few.

No comments:

Post a Comment